Marc W Meadows is an accomplished inventor based in Grand Haven, MI (US). He has made significant contributions to the field of pharmaceutical manufacturing, particularly through his innovative work on crystalline microspheres. With a total of 4 patents to his name, Meadows has established himself as a key figure in the development of advanced drug delivery systems.

Latest Patents

One of his notable patents is titled "Crystalline microspheres and the process of manufacturing the same." This invention relates to microspheres that comprise a core material, characterized by their perfect spherical shape and a moisture content of less than 1%. The method of manufacturing these microspheres is particularly useful in creating sustained and modified release active pharmaceutical ingredient (API) microspheres, serving as a free-flowing excipient for mini-tablets and in the production of API dispersions. Another patent under the same title focuses on microspheres with a circularity greater than 0.95 and an aspect ratio greater than 0.95, further enhancing their utility in pharmaceutical applications.

Career Highlights

Marc W Meadows is currently associated with Spi Pharma, Inc., where he continues to innovate in the field of pharmaceutical technology. His work has been instrumental in advancing the manufacturing processes of drug delivery systems, making them more efficient and effective.

Collaborations

Throughout his career, Meadows has collaborated with notable professionals in the industry, including Cecil W Propst and Michael S Todd. These collaborations have contributed to the successful development and implementation of his innovative ideas.

Conclusion

Marc W Meadows exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking work on crystalline microspheres. His contributions have the potential to significantly impact drug delivery systems, enhancing patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.